Research & Literature

Histologic features of alopecias: part II: scarring alopecias.

Bernárdez C, Molina-Ruiz AM, Requena L

Actas dermo-sifiliograficas 2015; (106(4)):260-70.

Folliculitis decalvans: a multicentre review of 82 patients.

Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.

Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients.

Tietze JK, Heppt MV, von Preußen A, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1816-21 doi:10.1111/jdv.13052.

Clinical, Trichoscopic, and Histopathological Features of Primary Cicatricial Alopecias: A Retrospective Observational Study at a Tertiary Care Centre of North East India.

Thakur BK, Verma S, Raphael V

International journal of trichology 2015; (7(3)):107-12 doi:10.4103/0974-7753.167459.

Central Centrifugal Cicatricial Alopecia in Children: A Case Series and Review of the Literature.

Eginli AN, Dlova NC, McMichael A

Pediatric dermatology 2017; (34(2)):133-137 doi:10.1111/pde.13046.

Epidermal psoriasiform hyperplasia, an unrecognized sign of folliculitis decalvans: A histological study of 26 patients.

Matard B, Cavelier-Balloy B, Reygagne P

Journal of cutaneous pathology 2017; (44(4)):352-357 doi:10.1111/cup.12892.

Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study.

Aksoy B, Hapa A, Mutlu E

International journal of dermatology 2018; (57(2)):250-253 doi:10.1111/ijd.13874.

Standardization of SMP Procedure and Its Impact On Outcome.

Dhurat RS, Shanshanwal SJS, Dandale AL

Journal of cutaneous and aesthetic surgery 2017; (10(3)):145-149 doi:10.4103/JCAS.JCAS_116_16.

Impact of Folliculitis Decalvans on Quality of Life and Subjective Perception of Disease.

Pindado-Ortega C, Saceda-Corralo D, Miguel-Gómez L, et al.

Skin appendage disorders 2018; (4(1)):34-36 doi:10.1159/000478053.

Inflammasome Activation Characterizes Lesional Skin of Folliculitis Decalvans.

Eyraud A, Milpied B, Thiolat D, et al.

Acta dermato-venereologica 2018; (98(6)):570-575 doi:10.2340/00015555-2924.

Cicatricial alopecia.

Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(4)):435-461 doi:10.1111/ddg.13498.

Lichen Planopilaris with Pustules: A Diagnostic Challenge.

Morais KL, Martins CF, Anzai A, et al.

Skin appendage disorders 2018; (4(2)):61-66 doi:10.1159/000478268.

Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.

Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.

Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.

Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66-patient case series and proposal of classification.

Lee CN, Chen W, Hsu CK, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(10)):1219-1226 doi:10.1111/ddg.13649.

Primary cicatricial alopecia in a single-race Asian population: A 10-year nationwide population-based study in South Korea.

Yoon J, Choi JW

The Journal of dermatology 2018; (45(11)):1306-1311 doi:10.1111/1346-8138.14625.

Tofacitinib for the treatment of lichen planopilaris: A case series.

Yang CC, Khanna T, Sallee B, et al.

Dermatologic therapy 2018; (31(6)):e12656 doi:10.1111/dth.12656.

Linear Circumscribed Scleroderma-Like Folliculitis Decalvans: Yet Another Face of a Protean Condition.

Rezende HD, Dias MFRG, Kempf W, Treüb RM

International journal of trichology 2018; (10(4)):175-179 doi:10.4103/ijt.ijt_9_18.

Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls.

Suchonwanit P, Udompanich S, Thadanipon K, Chanprapaph K

Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(4)):774-780 doi:10.1111/jdv.15421.

Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota.

Matard B, Donay JL, Resche-Rigon M, et al.

Experimental dermatology 2020; (29(3)):295-298 doi:10.1111/exd.13916.

Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.

Pimenta R, Borges-Costa J

Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.

Metastatic squamous cell carcinoma arising in the setting of folliculitis decalvans.

Esaa F, Shah PR, Dolohanty LB

Dermatology online journal 2019; (25(4)).

Evaluation of a Handheld Dermatoscope in Clinical Diagnosis of Primary Cicatricial Alopecias.

Karadag Köse Ö, Güleç AT

Dermatology and therapy 2019; (9(3)):525-535 doi:10.1007/s13555-019-0304-3.

Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.

Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al.

Skin appendage disorders 2019; (5(5)):309-315 doi:10.1159/000496708.

Folliculitis decalvans-like pustular plaques on the limbs sparing the scalp.

Yang A, Hannaford R, Kossard S

The Australasian journal of dermatology 2020; (61(1)):54-56 doi:10.1111/ajd.13178.

Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology.

Egger A, Stojadinovic O, Miteva M

The American Journal of dermatopathology 2020; (42(3)):173-177 doi:10.1097/DAD.0000000000001595.

Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.

Samrao A, Mirmirani P

Dermatology online journal 2020; (26(2)).

Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.

Uchiyama M, Harada K, Tobita R, et al.

Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.

Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease.

Bennett MR, Thomsen IP

Toxins 2020; (12(6)) doi:10.3390/toxins12060408.

An Overlap of Secondary Cutis Verticis Gyrata, Folliculitis Decalvans, Folliculitis Keloidalis Nuchae and the Use of Dreadlocks: The Role of Inflammation due to Traction.

Alonso Pereira L, Teixeira M, Andrade J, et al.

Skin appendage disorders 2017; (2(3-4)):130-134 doi:10.1159/000449006.

Common causes of hair loss - clinical manifestations, trichoscopy and therapy.

Alessandrini A, Bruni F, Piraccini BM, Starace M

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(3)):629-640 doi:10.1111/jdv.17079.

The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen at Mayo Clinic.

Imhof RL, Cantwell HM, Proffer SL, et al.

Pediatric dermatology 2021; (38(3)):580-584 doi:10.1111/pde.14543.

Photodynamic therapy should be considered for the treatment of folliculitis decalvans.

Yang L, Chen J, Tong X, et al.

Photodiagnosis and photodynamic therapy 2021; (35()):102356 doi:10.1016/j.pdpdt.2021.102356.

A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

Svigos K, Yin L, Fried L, et al.

American journal of clinical dermatology 2021; (22(5)):681-692 doi:10.1007/s40257-021-00630-7.

Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study.

Jerjen R, Pinczewski J, Sinclair R, Bhoyrul B

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(12)):2440-2447 doi:10.1111/jdv.17604.

Cicatricial pemphigoid Brunsting-Perry variant masquerading as neutrophil-mediated cicatricial alopecia.

Rahbar Z, Cohen JN, McCalmont TH, et al.

Journal of cutaneous pathology 2022; (49(4)):408-411 doi:10.1111/cup.14177.

Scarring Alopecias: Pathology and an Update on Digital Developments.

Cummins DM, Chaudhry IH, Harries M

Biomedicines 2021; (9(12)) doi:10.3390/biomedicines9121755.

Tufted hairs: A bouquet of flowers in different hair diseases.

Starace M, Vezzoni R, Alessandrini A, et al.

Journal of cosmetic dermatology 2022; (21(9)):3741-3746 doi:10.1111/jocd.14712.

Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans.

Ding L, DeGiovanni JC, Bogner P, Soofi Y

BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-247932.

Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response.

Moreno-Arrones OM, Garcia-Hoz C, Del Campo R, et al.

Dermatology (Basel, Switzerland) 2023; (239(3)):454-461 doi:10.1159/000529301.

Clinico-Epidemiology and Histopathologic Spectrum of Primary Scarring Alopecia: A Cross-Sectional Study.

Sardar S, Sarkar S, Podder I, Banerjee G

Indian journal of dermatology 2022; (67(5)):624 doi:10.4103/ijd.ijd_540_21.

Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study.

Dupont A, Eyraud A, Milpied B, et al.

Acta dermato-venereologica 2023; (103()):adv3713 doi:10.2340/actadv.v103.3713.

Tacrolimus in Solution as an Option to Inflammatory Conditions of the Scalp.

Scharf C, Licata G, Briatico G, et al.

Dermatology practical & conceptual 2023; (13(2)):e2023089 doi:10.5826/dpc.1302a89.

Health-related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review.

Singh R, Wilborn D, Lintzeri DA, Blume-Peytavi U

Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(12)):2462-2473 doi:10.1111/jdv.19381.

Cross-sectional study to evaluate the utility of elastic tissue staining in primary cicatricial alopecia.

Vishwanath T, Dhurat R

Journal of clinical pathology 2024; (77(11)):737-742 doi:10.1136/jcp-2022-208745.

Unveiling a Shared Precursor Condition for Acne Keloidalis Nuchae and Primary Cicatricial Alopecias.

Umar S, Ton D, Carter MJ, Shitabata P

Clinical, cosmetic and investigational dermatology 2023; (16()):2315-2327 doi:10.2147/CCID.S422310.

Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.

Lyakhovitsky A, Segal O, Galili E, et al.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.

Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.

Yu DA, Kim SR, Cho SI, Kwon O

The Journal of dermatology 2024; (51(3)):429-440 doi:10.1111/1346-8138.17080.

Comment on Topical Dapsone for Folliculitis Decalvans.

Trüeb RM, Luu NC, Rezende HD

International journal of trichology 2023; (15(3)):88-90 doi:10.4103/ijt.ijt_39_22.

Profibrotic Subsets of SPP1+ Macrophages and POSTN+ Fibroblasts Contribute to Fibrotic Scarring in Acne Keloidalis.

Hong YK, Hwang DY, Yang CC, et al.

The Journal of investigative dermatology 2024; (144(7)):1491-1504.e10 doi:10.1016/j.jid.2023.12.014.

Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients.

Melián-Olivera A, Moreno-Arrones Ó, Burgos-Blasco P, et al.

Acta dermato-venereologica 2024; (104()):adv12373 doi:10.2340/actadv.v104.12373.

Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions.

Franciozi AB, Sotto MN, Rivitti-Machado MCM, et al.

Clinical and experimental dermatology 2025; (50(3)):629-631 doi:10.1093/ced/llae421.

Compound Follicles in Folliculitis Decalvans Do Not Contain Vellus and Retained Telogen Follicles-A Pilot Histopathologic Series on Polytrichia.

Lee J, Miteva M

Journal of cutaneous pathology 2025; (52(1)):29-32 doi:10.1111/cup.14735.

Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

Folliculitis Decalvans: An Uncommon Case Report with Review of Literature.

Singh G, Pathania Y, Goswami P, et al.

International journal of applied & basic medical research 2025; (15(1)):63-65 doi:10.4103/ijabmr.ijabmr_414_24.

Squamous cell carcinoma originating in folliculitis decalvans.

Luu Y, Kimmis BD, Pulumati A, et al.

Dermatology online journal 2025; (31(1)) doi:10.5070/D331164986.

Epidemiological, Clinical, and Therapeutic Insights into Folliculitis Decalvans in Skin of Color: A Retrospective Descriptive Study of 17 Cases.

Loubaris Z, Taib HE, Benzekri L, Meziane M

Skin appendage disorders 2025; (11(6)):482-487 doi:10.1159/000546565.

Scalp Bacterial Profile and Antibiotics Susceptibility Pattern in Patients With Primary Cicatricial Alopecia.

Lee GJ, Kim SY, Tran TQT, et al.

Annals of dermatology 2025; (37(4)):241-249 doi:10.5021/ad.25.022.

A systematic review of procedural modalities in the treatment of lichen planopilaris, frontal fibrosing alopecia, and discoid lupus erythematosus.

Tanha AE, Ghane Y, Jafarzadeh A, Goodarzi A

Lasers in medical science 2025; (40(1)):431 doi:10.1007/s10103-025-04704-4.

Management of Folliculitis Decalvans: A Systematic Review.

Sideris E, Xie D, du Plessis J, de Zwaan S

The Australasian journal of dermatology 2025; (66(8)):448-461 doi:10.1111/ajd.14603.

Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?

Awad A, Kho YC, Asfour L, et al.

Experimental dermatology 2026; (35(1)):e70197 doi:10.1111/exd.70197.

Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets.

Svara F, Bortone G, Ambrosio L, et al.

Life (Basel, Switzerland) 2026; (16(5)) doi:10.3390/life16050835.

Multidimensional burden of scarring alopecia in women: findings from the CAPAIR study.

Levine J, O'Hagan R, Talia J, et al.

International journal of women's dermatology 2026; (12(3)):e268 doi:10.1097/JW9.0000000000000268.

Folliculitis decalvans in two families.

Bhoyrul B, Fahey V, Kho YC

Clinical and experimental dermatology 2026; doi:10.1093/ced/llag385.